News ESMO 2025: CheckMate 238 Update Reinforces Nivolumab Benefit by Medscape • 2026/01/27 • 0 Comments Dr Teresa Amaral discusses the 9-year update on CheckMate 238 presented at ESMO 2025. Medscape Oncology